170:@0.017061:0.038809:0.056572:0.038809:0.056572:0.019212:0.017061:0.019212:0.013170:0.013170:0.013170
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
classified as monofunctional, bifunctional :@0.084848:0.079499:0.481086:0.079499:0.481086:0.063743:0.084848:0.063743:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013181:0.007497:0.013143:0.007466:0.007491:0.018049:0.012604:0.011738:0.012604:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.007466:0.013123:0.003848:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330
or  trifunctional,  depending  on  whether :@0.084848:0.095083:0.481115:0.095083:0.481115:0.079327:0.084848:0.079327:0.012604:0.005792:0.005330:0.007541:0.006523:0.005792:0.003848:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.005330:0.005330:0.007551:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330:0.007545:0.012604:0.011738:0.005330:0.007543:0.015990:0.011738:0.012508:0.006523:0.011738:0.012508:0.005792:0.005330
the agent has one, two or three reactive :@0.084848:0.110667:0.481088:0.110667:0.481088:0.094911:0.084848:0.094911:0.006523:0.011738:0.012508:0.006985:0.013143:0.012950:0.012508:0.011738:0.006523:0.006983:0.011738:0.013143:0.007466:0.006995:0.012604:0.011738:0.012508:0.005330:0.006981:0.006523:0.015990:0.012604:0.006985:0.012604:0.005792:0.006983:0.006523:0.011738:0.005711:0.012508:0.012508:0.006989:0.005713:0.012508:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330
groups capable of interacting with the :@0.084848:0.126251:0.481082:0.126251:0.481082:0.110495:0.084848:0.110495:0.012950:0.005709:0.012604:0.011699:0.013123:0.007466:0.011488:0.012450:0.013143:0.013123:0.013143:0.013123:0.003848:0.012508:0.011488:0.012604:0.006042:0.011488:0.003848:0.011738:0.006523:0.012508:0.005792:0.013143:0.012450:0.006523:0.003848:0.011738:0.012950:0.011488:0.015990:0.003848:0.006523:0.011738:0.011488:0.006523:0.011738:0.012508:0.005330
cellular constituents.:@0.084848:0.141835:0.273732:0.141835:0.273732:0.126079:0.084848:0.126079:0.012450:0.012508:0.003848:0.003848:0.011699:0.003848:0.013143:0.005792:0.005330:0.012450:0.012604:0.011738:0.007466:0.006523:0.003848:0.006523:0.011699:0.012508:0.011738:0.006523:0.007466:0.005330
3,5,6:@0.273721:0.136221:0.298581:0.136221:0.298581:0.127035:0.273721:0.127035:0.006215:0.003107:0.006215:0.003107:0.006215
 :@0.298584:0.141840:0.303914:0.141840:0.303914:0.126084:0.298584:0.126084:0.005330
Therapeutically, the bifunctional agents :@0.103023:0.157424:0.481092:0.157424:0.481092:0.141668:0.103023:0.141668:0.008197:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.006340:0.006523:0.011738:0.012508:0.006335:0.013123:0.003848:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738:0.013143:0.003848:0.006350:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330
are the most effective alkylating agents.  :@0.084839:0.173008:0.471613:0.173011:0.471613:0.157255:0.084839:0.157252:0.013143:0.005715:0.012508:0.005330:0.006523:0.011738:0.012508:0.005330:0.018049:0.012604:0.007466:0.006523:0.005330:0.012508:0.006075:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.013143:0.003848:0.009660:0.010314:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.006223:0.759527
6:@0.460066:0.167392:0.466281:0.167392:0.466281:0.158206:0.460066:0.158206:0.006215
DNA-alkylating agents target rapidly di-:@0.103025:0.188595:0.475743:0.188595:0.475743:0.172839:0.103025:0.172839:0.014316:0.014239:0.014239:0.006388:0.013143:0.003848:0.009660:0.010314:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.006523:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.006514:0.006523:0.013143:0.005805:0.012950:0.012508:0.006523:0.006512:0.005792:0.013143:0.013123:0.003848:0.013181:0.003848:0.010314:0.006523:0.013181:0.003848:0.006388
viding cells. :@0.084841:0.204179:0.197178:0.204179:0.197178:0.188423:0.084841:0.188423:0.010660:0.003848:0.013181:0.003848:0.011738:0.012950:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330
Patients  may experience  dose-related :@0.103025:0.219762:0.481086:0.219762:0.481086:0.204007:0.103025:0.204007:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.005432:0.018049:0.013143:0.010314:0.010776:0.012508:0.009236:0.013123:0.012508:0.005792:0.003848:0.012508:0.011738:0.012450:0.012508:0.005330:0.005428:0.013181:0.012604:0.007466:0.012508:0.006388:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330
side effects that lead to myelosuppression :@0.084841:0.235346:0.481088:0.235346:0.481088:0.219590:0.084841:0.219590:0.007466:0.003848:0.013181:0.012508:0.005311:0.012508:0.006094:0.006042:0.012508:0.012450:0.006523:0.007466:0.005297:0.006523:0.011738:0.013143:0.006523:0.005294:0.003848:0.012508:0.013143:0.013181:0.005311:0.006523:0.012604:0.005294:0.018049:0.010314:0.012508:0.003848:0.012604:0.007466:0.011699:0.013123:0.013123:0.005719:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330
which involves bone marrow, lymphoid tis-:@0.084841:0.250930:0.475752:0.250930:0.475752:0.235174:0.084841:0.235174:0.015990:0.011738:0.003848:0.012450:0.011738:0.004855:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.007466:0.004868:0.013123:0.012604:0.011738:0.012508:0.004849:0.018049:0.013143:0.005792:0.005711:0.012604:0.015990:0.005330:0.004849:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.003848:0.013181:0.004868:0.006523:0.003848:0.007466:0.006388
sue, intestinal mucosa, hair cells and the :@0.084841:0.266514:0.481084:0.266514:0.481084:0.250758:0.084841:0.250758:0.007466:0.011699:0.012508:0.005330:0.008082:0.003848:0.011738:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.013143:0.003848:0.008093:0.018049:0.011699:0.012450:0.012604:0.007466:0.013143:0.005330:0.008082:0.011738:0.013143:0.003848:0.005792:0.008082:0.012450:0.012508:0.003848:0.003848:0.007466:0.008093:0.013143:0.011738:0.013181:0.008082:0.006523:0.011738:0.012508:0.005330
reproductive system.:@0.084841:0.282098:0.278358:0.282098:0.278358:0.266342:0.084841:0.266342:0.005713:0.012508:0.013123:0.005713:0.012604:0.013181:0.011699:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005330
3,6:@0.278362:0.276489:0.293900:0.276489:0.293900:0.267303:0.278362:0.267303:0.006215:0.003107:0.006215
Alkylating agents lack cross-resistance :@0.103030:0.297693:0.481061:0.297693:0.481061:0.281937:0.103030:0.281937:0.014239:0.003848:0.009660:0.010314:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.011238:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.011238:0.003848:0.013143:0.012450:0.009660:0.011238:0.012450:0.005711:0.012604:0.007466:0.007466:0.006388:0.005713:0.012508:0.007466:0.003848:0.007466:0.006523:0.013143:0.011738:0.012450:0.012508:0.005330
and thus combinations can be employed.  :@0.084846:0.313277:0.481087:0.313278:0.481087:0.297522:0.084846:0.297521:0.013143:0.011738:0.013181:0.003531:0.006523:0.011738:0.011699:0.007466:0.003525:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.003529:0.012450:0.013143:0.011738:0.003529:0.013123:0.012508:0.003529:0.012508:0.018049:0.013123:0.003848:0.012604:0.010314:0.012508:0.013181:0.005330:0.006219:0.546028
5:@0.469540:0.307659:0.475755:0.307659:0.475755:0.298474:0.469540:0.298474:0.006215
Combinations may reduce the likelihood :@0.084848:0.328862:0.481085:0.328862:0.481085:0.313106:0.084848:0.313106:0.015644:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.008140:0.018049:0.013143:0.010314:0.008140:0.005713:0.012508:0.013181:0.011699:0.012450:0.012508:0.008140:0.006523:0.011738:0.012508:0.008140:0.003848:0.003848:0.009660:0.012508:0.003848:0.003848:0.011738:0.012604:0.012604:0.013181:0.005330
of resistance and increase the therapeu-:@0.084848:0.344446:0.475757:0.344446:0.475757:0.328690:0.084848:0.328690:0.012604:0.006042:0.007455:0.005711:0.012508:0.007466:0.003848:0.007466:0.006523:0.013143:0.011738:0.012450:0.012508:0.007455:0.013143:0.011738:0.013181:0.007456:0.003848:0.011738:0.012450:0.005715:0.012508:0.013143:0.007466:0.012508:0.007466:0.006523:0.011738:0.012508:0.007456:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011688:0.006388
tic benefit.:@0.084848:0.360467:0.184100:0.360467:0.184100:0.344711:0.084848:0.344711:0.006523:0.003848:0.012450:0.005330:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.005330
5:@0.184086:0.354856:0.190301:0.354856:0.190301:0.345670:0.184086:0.345670:0.006215
NITROGEN MUSTARDS:@0.084848:0.389613:0.304212:0.389613:0.304212:0.371797:0.084848:0.371797:0.015822:0.005987:0.008980:0.012401:0.017960:0.017960:0.011118:0.015822:0.005987:0.019242:0.013683:0.011118:0.008980:0.015822:0.012401:0.014966:0.011118
Sulphur mustard was first synthesised as a :@0.084848:0.406345:0.481084:0.406345:0.481084:0.390589:0.084848:0.390589:0.009583:0.011699:0.003848:0.013123:0.011738:0.011699:0.005792:0.007233:0.018049:0.011699:0.007466:0.006523:0.013143:0.005677:0.013181:0.007237:0.015990:0.013143:0.007466:0.007243:0.004686:0.004686:0.005792:0.007466:0.006523:0.007229:0.007466:0.010314:0.011738:0.006523:0.011738:0.012508:0.007466:0.003848:0.007466:0.012508:0.013181:0.007241:0.013143:0.007466:0.007243:0.013143:0.005330
vesicant chemical warfare agent  in the :@0.084848:0.421929:0.481105:0.421929:0.481105:0.406173:0.084848:0.406173:0.010660:0.012508:0.007466:0.003848:0.012450:0.013143:0.011738:0.006523:0.009621:0.012450:0.011738:0.012508:0.018049:0.003848:0.012450:0.013143:0.003848:0.009621:0.015990:0.013143:0.006712:0.006042:0.013143:0.005713:0.012508:0.009621:0.013143:0.012950:0.012508:0.011738:0.006523:0.005330:0.004276:0.003848:0.011738:0.009621:0.006523:0.011738:0.012508:0.005330
late 19th century for use by the German :@0.084848:0.437512:0.481098:0.437512:0.481098:0.421757:0.084848:0.421757:0.003848:0.013143:0.006523:0.012508:0.007928:0.010660:0.010660:0.006523:0.011738:0.007918:0.012450:0.012508:0.011738:0.006523:0.011690:0.005792:0.010314:0.007918:0.006042:0.012604:0.005792:0.007912:0.011699:0.007466:0.012508:0.007928:0.013123:0.010314:0.007928:0.006523:0.011738:0.012508:0.007914:0.016779:0.012508:0.006321:0.018049:0.013143:0.011738:0.005330
army during World War I (WWI).:@0.084848:0.453096:0.373159:0.453096:0.373159:0.437340:0.084848:0.437340:0.013143:0.006325:0.018049:0.010314:0.005330:0.013181:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330:0.017580:0.012604:0.005792:0.003848:0.013181:0.005330:0.017507:0.013143:0.005792:0.005330:0.004349:0.005330:0.007100:0.018473:0.018473:0.004349:0.007100:0.005330
8-10:@0.373156:0.447481:0.395525:0.447481:0.395525:0.438296:0.373156:0.438296:0.006215:0.003724:0.006215:0.006215
 :@0.395532:0.453100:0.400862:0.453100:0.400862:0.437344:0.395532:0.437344:0.005330
During  WWI, physicians observed that :@0.103028:0.468684:0.481093:0.468684:0.481093:0.452928:0.103028:0.452928:0.014316:0.011699:0.005792:0.003848:0.011738:0.012950:0.005330:0.005879:0.018473:0.018473:0.004349:0.005330:0.011218:0.013123:0.011738:0.010314:0.007466:0.003848:0.012450:0.003848:0.013143:0.011738:0.007466:0.011218:0.012604:0.013123:0.007466:0.012508:0.005792:0.010660:0.012508:0.013181:0.011218:0.006523:0.011738:0.013143:0.006523:0.005330
soldiers exposed to sulphur mustard or :@0.084844:0.484268:0.481084:0.484268:0.481084:0.468512:0.084844:0.468512:0.007466:0.012604:0.003848:0.013181:0.003848:0.012508:0.005792:0.007466:0.012989:0.012508:0.009236:0.013123:0.012604:0.007466:0.012508:0.013181:0.012989:0.006523:0.012604:0.012989:0.007466:0.011699:0.003848:0.013123:0.011738:0.011699:0.005792:0.012989:0.018049:0.011699:0.007466:0.006523:0.013143:0.005677:0.013181:0.012989:0.012604:0.005792:0.005330
mustard gas had severe  bone-marrow :@0.084844:0.499852:0.481099:0.499852:0.481099:0.484096:0.084844:0.484096:0.018049:0.011699:0.007466:0.006523:0.013143:0.005677:0.013181:0.013643:0.012950:0.013143:0.007466:0.013643:0.011738:0.013143:0.013181:0.013643:0.007466:0.012508:0.010660:0.012508:0.005715:0.012508:0.005330:0.008303:0.013123:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005702:0.012604:0.015990:0.005330
suppression.  :@0.084844:0.515436:0.208487:0.515441:0.208487:0.499685:0.084844:0.499680:0.007466:0.011699:0.013123:0.013123:0.005719:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.006221:0.524573
1:@0.196939:0.509822:0.203154:0.509822:0.203154:0.500637:0.196939:0.500637:0.006215
This observation led to the recognition of :@0.103038:0.531025:0.481117:0.531025:0.481117:0.515269:0.103038:0.515269:0.008197:0.011738:0.003848:0.007466:0.004483:0.012604:0.013123:0.007466:0.012508:0.005792:0.010660:0.013143:0.006523:0.003848:0.012604:0.011738:0.004483:0.003848:0.012508:0.013181:0.004483:0.006523:0.012604:0.004483:0.006523:0.011738:0.012508:0.004483:0.005713:0.012508:0.012450:0.012604:0.012950:0.011738:0.003848:0.006523:0.003848:0.012604:0.011738:0.004470:0.012604:0.006042:0.005330
the  potential cytotoxicity  of alkylating :@0.084854:0.546609:0.481103:0.546609:0.481103:0.530853:0.084854:0.530853:0.006523:0.011738:0.012508:0.005330:0.010010:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.015355:0.012450:0.010314:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.010314:0.005330:0.010012:0.012604:0.006042:0.015355:0.013143:0.003848:0.009660:0.010314:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330
agents and the development of nitrogen :@0.084854:0.562193:0.481109:0.562193:0.481109:0.546437:0.084854:0.546437:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.006850:0.013143:0.011738:0.013181:0.006850:0.006523:0.011738:0.012508:0.006850:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.018049:0.012508:0.011738:0.006523:0.006850:0.012604:0.006042:0.006850:0.011738:0.003848:0.006523:0.005711:0.012604:0.012950:0.012508:0.011738:0.005330
mustards.  :@0.084854:0.577777:0.184931:0.577782:0.184931:0.562027:0.084854:0.562021:0.018049:0.011699:0.007466:0.006523:0.013143:0.005677:0.013181:0.007466:0.005330:0.006213:0.457450
1:@0.173384:0.572163:0.179599:0.572163:0.179599:0.562978:0.173384:0.562978:0.006215
Individuals  exposed to  nitrogen  mus-:@0.103036:0.593366:0.475767:0.593366:0.475767:0.577611:0.103036:0.577611:0.004349:0.011738:0.013181:0.003848:0.010660:0.003848:0.013181:0.011699:0.013143:0.003848:0.007466:0.005330:0.008386:0.012508:0.009236:0.013123:0.012604:0.007466:0.012508:0.013181:0.013701:0.006523:0.012604:0.005330:0.008361:0.011738:0.003848:0.006523:0.005711:0.012604:0.012950:0.012508:0.011738:0.005330:0.008355:0.018049:0.011699:0.007466:0.006388
tards developed severe irritating  symp-:@0.084852:0.608950:0.475769:0.608950:0.475769:0.593194:0.084852:0.593194:0.006523:0.013143:0.005675:0.013181:0.007466:0.012527:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.012508:0.013181:0.012527:0.007466:0.012508:0.010660:0.012508:0.005715:0.012508:0.012527:0.003848:0.005792:0.005792:0.003848:0.006523:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.007187:0.007466:0.010314:0.018049:0.013123:0.006388
toms affecting the  respiratory tract,  mu-:@0.084852:0.624534:0.475788:0.624534:0.475788:0.608778:0.084852:0.608778:0.006523:0.012604:0.018049:0.007466:0.009506:0.013143:0.006100:0.006042:0.012508:0.012450:0.006523:0.003848:0.011738:0.012950:0.009506:0.006523:0.011738:0.012508:0.005330:0.004162:0.005713:0.012508:0.007466:0.013123:0.003848:0.005792:0.013143:0.006523:0.012604:0.005792:0.010314:0.009506:0.006523:0.005792:0.013143:0.012450:0.006523:0.005330:0.005330:0.004160:0.018049:0.011699:0.006388
cous:@0.084852:0.640118:0.129071:0.640118:0.129071:0.624362:0.084852:0.624362:0.012450:0.012604:0.011699:0.007466
membranes,:@0.155260:0.640118:0.272965:0.640118:0.272965:0.624362:0.155260:0.624362:0.018049:0.012508:0.018049:0.013123:0.005792:0.013143:0.011738:0.012508:0.007466:0.005330
skin,:@0.299154:0.640118:0.337197:0.640118:0.337197:0.624362:0.299154:0.624362:0.007466:0.009660:0.003848:0.011738:0.005330
eyes,:@0.363386:0.640118:0.411511:0.640118:0.411511:0.624362:0.363386:0.624362:0.012508:0.010314:0.012508:0.007466:0.005330
and:@0.437700:0.640118:0.475761:0.640118:0.475761:0.624362:0.437700:0.624362:0.013143:0.011738:0.013181
endocrine- and immune systems.:@0.084852:0.655702:0.392672:0.655702:0.392672:0.639946:0.084852:0.639946:0.012508:0.011738:0.013181:0.012604:0.012450:0.005792:0.003848:0.011738:0.012508:0.006388:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.005330:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.007466:0.005330
10,11:@0.392652:0.650090:0.420619:0.650090:0.420619:0.640904:0.392652:0.640904:0.006215:0.006215:0.003107:0.006215:0.006215
 :@0.420626:0.655709:0.425956:0.655709:0.425956:0.639953:0.420626:0.639953:0.005330
As lymphocytes are particularly suscep-:@0.103030:0.671293:0.475756:0.671293:0.475756:0.655537:0.103030:0.655537:0.014239:0.007466:0.006523:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.012508:0.007466:0.006523:0.013143:0.005715:0.012508:0.006523:0.013123:0.013143:0.005792:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.003848:0.010314:0.006523:0.007466:0.011699:0.007466:0.012450:0.012508:0.013123:0.006388
tible to  the  cytotoxic  effects  of  nitrogen :@0.084846:0.686877:0.481101:0.686877:0.481101:0.671121:0.084846:0.671121:0.006523:0.003848:0.013123:0.003848:0.012508:0.009140:0.006523:0.012604:0.005330:0.003795:0.006523:0.011738:0.012508:0.005330:0.003795:0.012450:0.010314:0.006523:0.012604:0.006523:0.012604:0.009236:0.003848:0.012450:0.005330:0.003791:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.003800:0.012604:0.006042:0.005330:0.003797:0.011738:0.003848:0.006523:0.005711:0.012604:0.012950:0.012508:0.011738:0.005330
mustards, these  agents are used in the :@0.084846:0.702461:0.481115:0.702461:0.481115:0.686705:0.084846:0.686705:0.018049:0.011699:0.007466:0.006523:0.013143:0.005677:0.013181:0.007466:0.005330:0.010795:0.006523:0.011738:0.012508:0.007466:0.012508:0.005330:0.005455:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.010795:0.013143:0.005715:0.012508:0.010795:0.011699:0.007466:0.012508:0.013181:0.010795:0.003848:0.011738:0.010795:0.006523:0.011738:0.012508:0.005330
palliation of chronic lymphatic leukaemias :@0.084846:0.718045:0.481067:0.718045:0.481067:0.702289:0.084846:0.702289:0.013123:0.013143:0.003848:0.003848:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.004291:0.012604:0.006042:0.004278:0.012450:0.011738:0.005713:0.012604:0.011738:0.003848:0.012450:0.004278:0.003848:0.010314:0.018049:0.013123:0.011738:0.013143:0.006523:0.003848:0.012450:0.004281:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.007466:0.005330
and malignant lymphomas.  :@0.084846:0.733629:0.359980:0.733635:0.359980:0.717879:0.084846:0.717873:0.013143:0.011738:0.013181:0.005330:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330:0.012437:0.055707
12:@0.342215:0.728016:0.354645:0.728016:0.354645:0.718831:0.342215:0.718831:0.006215:0.006215
Cyclophosphamide is the most frequently :@0.103036:0.749219:0.481113:0.749219:0.481113:0.733463:0.103036:0.733463:0.015221:0.009891:0.012027:0.003425:0.012180:0.012700:0.011315:0.012180:0.007043:0.012700:0.011315:0.012719:0.017626:0.003425:0.012758:0.012084:0.005253:0.003425:0.007043:0.005253:0.006100:0.011315:0.012084:0.005253:0.017626:0.012180:0.007043:0.006100:0.005253:0.005619:0.005290:0.012084:0.012700:0.011276:0.012084:0.011315:0.006100:0.003425:0.010318:0.005330
used alkylating agent in chemotherapy.  :@0.084852:0.764803:0.453741:0.764806:0.453741:0.749050:0.084852:0.749047:0.011276:0.007043:0.012084:0.012758:0.004907:0.012719:0.003425:0.009236:0.009891:0.003425:0.012719:0.006100:0.003425:0.011315:0.012527:0.004907:0.012719:0.012527:0.012084:0.011315:0.006100:0.004907:0.003425:0.011315:0.004907:0.012027:0.011315:0.012084:0.017626:0.012180:0.006100:0.011315:0.012084:0.005369:0.012719:0.012700:0.009891:0.005330:0.005766:-0.083393
5:@0.442194:0.759187:0.448409:0.759187:0.448409:0.750001:0.442194:0.750001:0.006215
Cyclophosphamide and ifosfamide are :@0.103029:0.780390:0.481062:0.780390:0.481062:0.764634:0.103029:0.764634:0.015221:0.009891:0.012027:0.003425:0.012180:0.012700:0.011315:0.012180:0.007043:0.012700:0.011315:0.012719:0.017626:0.003425:0.012758:0.012084:0.011430:0.012719:0.011315:0.012758:0.011430:0.003425:0.005619:0.012180:0.007043:0.005619:0.012719:0.017626:0.003425:0.012758:0.012084:0.011430:0.012719:0.005290:0.012506:0.005330
prodrugs that require activation via the cy-:@0.084845:0.795974:0.475756:0.795974:0.475756:0.780218:0.084845:0.780218:0.012700:0.005290:0.012180:0.012758:0.005369:0.011276:0.012527:0.007043:0.006492:0.006100:0.011315:0.012719:0.006100:0.006494:0.005288:0.012084:0.012700:0.011276:0.003425:0.005290:0.012084:0.006492:0.012719:0.012027:0.006100:0.003425:0.010237:0.012719:0.006100:0.003425:0.012180:0.011315:0.006492:0.010237:0.003425:0.012719:0.006492:0.006100:0.011315:0.012084:0.006492:0.012027:0.009891:0.006388
tochrome P450 family of drug-metabolising :@0.084845:0.811558:0.481087:0.811558:0.481087:0.795802:0.084845:0.795802:0.006100:0.012180:0.012027:0.011315:0.005290:0.012180:0.017626:0.012084:0.006760:0.010968:0.010237:0.010237:0.010237:0.006760:0.005619:0.012719:0.017626:0.003425:0.003425:0.009891:0.006762:0.012180:0.005619:0.006760:0.012758:0.005369:0.011276:0.012527:0.005965:0.017626:0.012084:0.006100:0.012719:0.012700:0.012180:0.003425:0.003425:0.007043:0.003425:0.011315:0.012948:0.005330
enzymes.  :@0.084845:0.827142:0.187922:0.827147:0.187922:0.811391:0.084845:0.811386:0.012084:0.011315:0.007755:0.009891:0.017626:0.012084:0.007043:0.005330:0.014619:0.091749
5,6:@0.167545:0.821528:0.182589:0.821528:0.182589:0.812342:0.167545:0.812342:0.005968:0.002861:0.006215
Acrolein, a metabolite of cyclophospha-:@0.103024:0.842731:0.475767:0.842731:0.475767:0.826975:0.103024:0.826975:0.013816:0.012027:0.005290:0.012180:0.003425:0.012084:0.003425:0.011315:0.004907:0.007351:0.012719:0.007351:0.017626:0.012084:0.006100:0.012719:0.012700:0.012180:0.003425:0.003425:0.006100:0.012084:0.007351:0.012180:0.005619:0.007351:0.012027:0.009891:0.012027:0.003425:0.012180:0.012700:0.011315:0.012180:0.007043:0.012700:0.011315:0.012719:0.006388
mide and ifosfamide, can induce bladder :@0.084840:0.858315:0.481076:0.858315:0.481076:0.842559:0.084840:0.842559:0.017626:0.003425:0.012758:0.012084:0.007928:0.012719:0.011315:0.012758:0.007928:0.003425:0.005619:0.012180:0.007043:0.005619:0.012719:0.017626:0.003425:0.012758:0.012084:0.004907:0.007928:0.012027:0.012719:0.011315:0.007928:0.003425:0.011315:0.012758:0.011276:0.012027:0.012084:0.007928:0.012700:0.003425:0.012719:0.012758:0.012758:0.012084:0.005788:0.005330
toxicity which can lead to haemorrhagic :@0.084840:0.873899:0.481072:0.873899:0.481072:0.858143:0.084840:0.858143:0.006100:0.012180:0.008813:0.003425:0.012027:0.003425:0.006100:0.009891:0.010064:0.015567:0.011315:0.003425:0.012027:0.011315:0.010064:0.012027:0.012719:0.011315:0.010064:0.003425:0.012084:0.012719:0.012758:0.010064:0.006100:0.012180:0.010064:0.011315:0.012719:0.012084:0.017626:0.012180:0.005369:0.005919:0.011315:0.012719:0.012527:0.003425:0.012450:0.005330
cystitis. To prevent this side effect, 2-mercap-:@0.084840:0.889483:0.475740:0.889483:0.475740:0.873727:0.084840:0.873727:0.012027:0.009891:0.007043:0.006100:0.003425:0.006100:0.003425:0.007043:0.004907:0.004243:0.006829:0.012180:0.004243:0.012700:0.005290:0.012084:0.010237:0.012084:0.011315:0.006100:0.004241:0.006100:0.011315:0.003425:0.007043:0.004243:0.007043:0.003425:0.012758:0.012084:0.004243:0.012084:0.005675:0.005619:0.012084:0.012027:0.006100:0.004907:0.004243:0.010237:0.005965:0.017626:0.012084:0.005232:0.012027:0.012719:0.012700:0.006388
toethanesulphonate (MESNA) is co-adminis-:@0.084840:0.905067:0.475755:0.905067:0.475755:0.889311:0.084840:0.889311:0.006100:0.012180:0.012084:0.006100:0.011315:0.012719:0.011315:0.012084:0.007043:0.011276:0.003425:0.012700:0.011315:0.012180:0.011315:0.012719:0.006100:0.012084:0.004743:0.006677:0.017260:0.009891:0.009159:0.013816:0.013816:0.006677:0.004741:0.003425:0.007043:0.004741:0.012027:0.012180:0.005965:0.012719:0.012758:0.017626:0.003425:0.011315:0.003425:0.007043:0.006388
tered in cyclophosphamide and ifosfa- :@0.084840:0.920651:0.481080:0.920651:0.481080:0.904895:0.084840:0.904895:0.006100:0.012084:0.005290:0.012084:0.012758:0.015663:0.003425:0.011315:0.015663:0.012027:0.009891:0.012027:0.003425:0.012180:0.012700:0.011315:0.012180:0.007043:0.012700:0.011315:0.012719:0.017626:0.003425:0.012758:0.012084:0.015663:0.012719:0.011315:0.012758:0.015663:0.003425:0.005619:0.012180:0.007043:0.005619:0.012719:0.006390:0.005330
mide therapy.  :@0.084840:0.936235:0.222272:0.936244:0.222272:0.920488:0.084840:0.920479:0.017626:0.003425:0.012758:0.012084:0.004907:0.006100:0.011315:0.012084:0.005369:0.012719:0.012700:0.009891:0.005330:0.005795:-0.101288
5:@0.210725:0.930625:0.216940:0.930625:0.216940:0.921439:0.210725:0.921439:0.006215
Detailed indications for each of the nitro-:@0.524244:0.079497:0.915165:0.079497:0.915165:0.063741:0.524244:0.063741:0.014316:0.012508:0.006523:0.013143:0.003848:0.003848:0.012508:0.013181:0.006696:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.006696:0.006042:0.012604:0.005792:0.006683:0.012508:0.013143:0.012450:0.011738:0.006696:0.012604:0.006042:0.006696:0.006523:0.011738:0.012508:0.006687:0.011738:0.003848:0.006523:0.005711:0.012604:0.006388
gen mustards follow.:@0.524244:0.094935:0.715561:0.094935:0.715561:0.079179:0.524244:0.079179:0.012950:0.012508:0.011738:0.005330:0.018049:0.011699:0.007466:0.006523:0.013143:0.005667:0.013181:0.007466:0.005330:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.005330
Indications:@0.524242:0.122311:0.636339:0.122311:0.636339:0.104805:0.524242:0.104805:0.004832:0.013042:0.014646:0.004276:0.013833:0.014603:0.007248:0.004276:0.014004:0.013042:0.008296
13-15:@0.636343:0.116068:0.668103:0.116068:0.668103:0.105862:0.636343:0.105862:0.006905:0.006905:0.004138:0.006905:0.006905
Chlorambucil:@0.524242:0.141424:0.664498:0.141424:0.664498:0.123609:0.524242:0.123609:0.016677:0.012828:0.005131:0.013683:0.006842:0.014111:0.020098:0.014111:0.012828:0.013683:0.005131:0.005131
n :@0.524242:0.155478:0.537570:0.155478:0.537570:0.147038:0.524242:0.147038:0.009762:0.003566
 :@0.554542:0.155478:0.558108:0.155478:0.558108:0.147038:0.554542:0.147038:0.003566
Hodgkin’s disease:@0.554545:0.158597:0.721338:0.158597:0.721338:0.142841:0.554545:0.142841:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
n :@0.524242:0.171504:0.537570:0.171504:0.537570:0.163064:0.524242:0.163064:0.009762:0.003566
 :@0.554542:0.171504:0.558108:0.171504:0.558108:0.163064:0.554542:0.163064:0.003566
Certain forms of non-Hodgkin’s :@0.554545:0.174623:0.847974:0.174623:0.847974:0.158867:0.554545:0.158867:0.015644:0.012508:0.005792:0.006514:0.013143:0.003848:0.011738:0.005330:0.006042:0.012604:0.006319:0.018049:0.007466:0.005330:0.012604:0.006042:0.005330:0.011738:0.012604:0.011738:0.006388:0.013143:0.012604:0.013181:0.012935:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330
lymphoma:@0.554545:0.190062:0.655414:0.190062:0.655414:0.174306:0.554545:0.174306:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143
n :@0.524242:0.202969:0.537570:0.202969:0.537570:0.194528:0.524242:0.194528:0.009762:0.003566
 :@0.554542:0.202969:0.558108:0.202969:0.558108:0.194528:0.554542:0.194528:0.003566
Chronic lymphocytic leukaemia :@0.554545:0.206088:0.857934:0.206088:0.857934:0.190332:0.554545:0.190332:0.015644:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.005330:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330
n :@0.524242:0.218995:0.537570:0.218995:0.537570:0.210555:0.524242:0.210555:0.009762:0.003566
 :@0.554542:0.218995:0.558108:0.218995:0.558108:0.210555:0.554542:0.210555:0.003566
Waldenstrom’s macroglobulinaemia :@0.554545:0.222114:0.898018:0.222114:0.898018:0.206358:0.554545:0.206358:0.017514:0.013143:0.003848:0.013181:0.012508:0.011738:0.007466:0.006523:0.005709:0.012604:0.018049:0.006754:0.007466:0.005330:0.018049:0.013143:0.012450:0.005713:0.012604:0.012950:0.003848:0.012604:0.013123:0.011699:0.003848:0.003848:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330
Cyclophosphamide:@0.524242:0.254637:0.729922:0.254637:0.729922:0.236822:0.524242:0.236822:0.016677:0.012401:0.013683:0.005131:0.013683:0.014111:0.012828:0.013683:0.009407:0.014111:0.012828:0.014111:0.020098:0.005131:0.014111:0.013683
n :@0.524242:0.268691:0.537570:0.268691:0.537570:0.260250:0.524242:0.260250:0.009762:0.003566
 :@0.554542:0.268691:0.558108:0.268691:0.558108:0.260250:0.554542:0.260250:0.003566
Alone or in combination with other :@0.554545:0.271810:0.882360:0.271810:0.882360:0.256054:0.554545:0.256054:0.014239:0.003848:0.012604:0.011738:0.012508:0.005330:0.012604:0.005792:0.005330:0.003848:0.011738:0.005330:0.012433:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330
cytostatic agents for various cancers :@0.554545:0.287248:0.902563:0.287248:0.902563:0.271492:0.554545:0.271492:0.012450:0.010314:0.006523:0.012604:0.007466:0.006523:0.013143:0.006523:0.003848:0.012450:0.005330:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.005330:0.006042:0.012604:0.005792:0.005330:0.010660:0.013143:0.005792:0.003848:0.012604:0.011699:0.007466:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330
of the neoplastic disease of the :@0.554545:0.302687:0.852725:0.302687:0.852725:0.286931:0.554545:0.286931:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.003848:0.012450:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.012508:0.005330
reticulo-endothelial system, such as :@0.554545:0.318125:0.888553:0.318125:0.888553:0.302369:0.554545:0.302369:0.005713:0.012508:0.006523:0.003848:0.012450:0.011699:0.003848:0.012604:0.006388:0.012508:0.011738:0.013181:0.012604:0.006523:0.011738:0.012508:0.003848:0.003848:0.013143:0.003848:0.005330:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005330:0.005330:0.007466:0.011699:0.012450:0.011738:0.005330:0.013143:0.007466:0.005330
lymphomas, lymphosarcomas, :@0.554545:0.333563:0.843862:0.333563:0.843862:0.317807:0.554545:0.317807:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.007466:0.005330:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.007466:0.013143:0.005665:0.012450:0.012604:0.018049:0.013143:0.007466:0.005330:0.005330
reticulo-sarcomas, Hodgkin’s disease, :@0.554545:0.349002:0.908220:0.349002:0.908220:0.333246:0.554545:0.333246:0.005713:0.012508:0.006523:0.003848:0.012450:0.011699:0.003848:0.012604:0.006388:0.007466:0.013143:0.005659:0.012450:0.012604:0.018049:0.013143:0.007466:0.005330:0.005330:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.005330
chronic lymphatic leukaemias, :@0.554545:0.364440:0.845311:0.364440:0.845311:0.348684:0.554545:0.348684:0.012450:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.013143:0.006523:0.003848:0.012450:0.005330:0.003848:0.012508:0.011699:0.009660:0.013143:0.012508:0.018049:0.003848:0.013143:0.007466:0.005330:0.005330
multiple myelomas:@0.554545:0.379879:0.729304:0.379879:0.729304:0.364123:0.554545:0.364123:0.018049:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.005330:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.007466
n :@0.524242:0.392785:0.537570:0.392785:0.537570:0.384345:0.524242:0.384345:0.009762:0.003566
 :@0.554542:0.392785:0.558108:0.392785:0.558108:0.384345:0.554542:0.384345:0.003566
Adjunctive chemotherapy agent in :@0.554545:0.395904:0.889555:0.395904:0.889555:0.380148:0.554545:0.380148:0.014239:0.013181:0.003906:0.011699:0.011738:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013143:0.012950:0.012508:0.011738:0.006523:0.005330:0.003848:0.011738:0.005330
surgery and/or radiotherapy :@0.554545:0.411342:0.823648:0.411342:0.823648:0.395586:0.554545:0.395586:0.007466:0.011699:0.005809:0.012950:0.012508:0.005792:0.010314:0.005330:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
n :@0.524242:0.424249:0.537570:0.424249:0.537570:0.415809:0.524242:0.415809:0.009762:0.003566
 :@0.554542:0.424249:0.558108:0.424249:0.558108:0.415809:0.554542:0.415809:0.003566
As palliative therapy in inoperable :@0.554545:0.427368:0.878366:0.427368:0.878366:0.411612:0.554545:0.411612:0.014239:0.007466:0.005330:0.013123:0.013143:0.003848:0.003848:0.003848:0.013143:0.006523:0.003848:0.010660:0.012527:0.005330:0.006523:0.011738:0.012498:0.005792:0.013143:0.013123:0.010314:0.005330:0.003848:0.011738:0.005330:0.003848:0.011738:0.012604:0.013123:0.012508:0.005792:0.013143:0.013123:0.003848:0.012508:0.005330
malignancies:@0.554545:0.442807:0.679274:0.442807:0.679274:0.427051:0.554545:0.427051:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.003848:0.012508:0.007466
n :@0.524242:0.455714:0.537570:0.455714:0.537570:0.447274:0.524242:0.447274:0.009762:0.003566
 :@0.554542:0.455714:0.558108:0.455714:0.558108:0.447274:0.554542:0.447274:0.003566
Progressive auto-immune disease:@0.554545:0.458833:0.864402:0.458833:0.864402:0.443077:0.554545:0.443077:0.011392:0.005713:0.012604:0.012950:0.005713:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.005330:0.013143:0.011699:0.006523:0.012604:0.006388:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
n :@0.524242:0.471740:0.537570:0.471740:0.537570:0.463300:0.524242:0.463300:0.009762:0.003566
 :@0.554542:0.471740:0.558108:0.471740:0.558108:0.463300:0.554542:0.463300:0.003566
Ovarian cancer:@0.554545:0.474859:0.703000:0.474859:0.703000:0.459103:0.554545:0.459103:0.016722:0.010660:0.013143:0.005792:0.003848:0.013143:0.011738:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
96:@0.702997:0.469240:0.715427:0.469240:0.715427:0.460055:0.702997:0.460055:0.006215:0.006215
Estramustine:@0.524242:0.501649:0.652524:0.501649:0.652524:0.483834:0.524242:0.483834:0.011118:0.009407:0.006414:0.006842:0.014111:0.020098:0.012828:0.009407:0.006414:0.005131:0.012828:0.013683
n :@0.524242:0.515703:0.537570:0.515703:0.537570:0.507263:0.524242:0.507263:0.009762:0.003566
 :@0.554542:0.515703:0.558108:0.515703:0.558108:0.507263:0.554542:0.507263:0.003566
Advanced prostate cancer:@0.554545:0.518822:0.811978:0.518822:0.811978:0.503066:0.554545:0.503066:0.014239:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330:0.013123:0.005713:0.012604:0.007466:0.006523:0.013143:0.006523:0.012508:0.005330:0.012450:0.013143:0.011738:0.012450:0.012498:0.005792
Ifosfamide:@0.524242:0.545612:0.632427:0.545612:0.632427:0.527797:0.524242:0.527797:0.005987:0.005987:0.013683:0.009407:0.005987:0.014111:0.020098:0.005131:0.014111:0.013683
n :@0.524242:0.559666:0.537570:0.559666:0.537570:0.551226:0.524242:0.551226:0.009762:0.003566
 :@0.554542:0.559666:0.558108:0.559666:0.558108:0.551226:0.554542:0.551226:0.003566
Oat-cell bronchogenic carcinoma :@0.554545:0.562785:0.882514:0.562785:0.882514:0.547029:0.554545:0.547029:0.016722:0.013143:0.006523:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.013123:0.005719:0.012604:0.011738:0.012450:0.011738:0.012604:0.012950:0.012508:0.011738:0.003848:0.012450:0.005330:0.012450:0.013143:0.005655:0.012450:0.003848:0.011738:0.012604:0.018049:0.013143:0.005330
n :@0.524242:0.575692:0.537570:0.575692:0.537570:0.567252:0.524242:0.567252:0.009762:0.003566
 :@0.554542:0.575692:0.558108:0.575692:0.558108:0.567252:0.554542:0.567252:0.003566
Ovarian cancer :@0.554545:0.578811:0.708330:0.578811:0.708330:0.563055:0.554545:0.563055:0.016722:0.010660:0.013143:0.005792:0.003848:0.013143:0.011738:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
n :@0.524242:0.591719:0.537570:0.591719:0.537570:0.583278:0.524242:0.583278:0.009762:0.003566
 :@0.554542:0.591719:0.558108:0.591719:0.558108:0.583278:0.554542:0.583278:0.003566
Mammary cancer:@0.554545:0.594838:0.724128:0.594838:0.724128:0.579082:0.554545:0.579082:0.017684:0.013143:0.018049:0.018049:0.013143:0.005792:0.010314:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
n :@0.524242:0.607745:0.537570:0.607745:0.537570:0.599305:0.524242:0.599305:0.009762:0.003566
 :@0.554542:0.607745:0.558108:0.607745:0.558108:0.599305:0.554542:0.599305:0.003566
Pancreatic cancer:@0.554545:0.610864:0.730859:0.610864:0.730859:0.595108:0.554545:0.595108:0.011392:0.013143:0.011738:0.012450:0.005711:0.012508:0.013143:0.006523:0.003848:0.012450:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
n :@0.524242:0.623771:0.537570:0.623771:0.537570:0.615331:0.524242:0.615331:0.009762:0.003566
 :@0.554542:0.623771:0.558108:0.623771:0.558108:0.615331:0.554542:0.615331:0.003566
Testicular tumours:@0.554545:0.626890:0.718240:0.626890:0.718240:0.611134:0.554545:0.611134:0.007254:0.012508:0.007466:0.006523:0.003848:0.012450:0.011699:0.003848:0.013143:0.005792:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466
n :@0.524242:0.639797:0.537570:0.639797:0.537570:0.631357:0.524242:0.631357:0.009762:0.003566
 :@0.554542:0.639797:0.558108:0.639797:0.558108:0.631357:0.554542:0.631357:0.003566
Hypernephroma :@0.554545:0.642916:0.713762:0.642916:0.713762:0.627161:0.554545:0.627161:0.013143:0.010314:0.013123:0.012508:0.006190:0.011738:0.012508:0.013123:0.011738:0.005707:0.012604:0.018049:0.013143:0.005330
n :@0.524242:0.655824:0.537570:0.655824:0.537570:0.647383:0.524242:0.647383:0.009762:0.003566
 :@0.554542:0.655824:0.558108:0.655824:0.558108:0.647383:0.554542:0.647383:0.003566
Malignant lymphoma :@0.554545:0.658943:0.760689:0.658943:0.760689:0.643187:0.554545:0.643187:0.017684:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.005330:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330
n :@0.524242:0.671850:0.537570:0.671850:0.537570:0.663410:0.524242:0.663410:0.009762:0.003566
 :@0.554542:0.671850:0.558108:0.671850:0.558108:0.663410:0.554542:0.663410:0.003566
Chondro-osteosarcoma:@0.554545:0.674969:0.778373:0.674969:0.778373:0.659213:0.554545:0.659213:0.015644:0.011738:0.012604:0.011738:0.013181:0.005711:0.012604:0.006388:0.012604:0.007466:0.006523:0.012508:0.012604:0.007466:0.013143:0.005661:0.012450:0.012604:0.018049:0.013143
n :@0.524242:0.687876:0.537570:0.687876:0.537570:0.679436:0.524242:0.679436:0.009762:0.003566
Leiomyosarcoma:@0.554545:0.690995:0.715875:0.690995:0.715875:0.675239:0.554545:0.675239:0.008890:0.012508:0.003848:0.012604:0.018049:0.010314:0.012604:0.007466:0.013143:0.005659:0.012450:0.012604:0.018049:0.013143
n :@0.524242:0.703902:0.537570:0.703902:0.537570:0.695462:0.524242:0.695462:0.009762:0.003566
 :@0.554542:0.703902:0.558108:0.703902:0.558108:0.695462:0.554542:0.695462:0.003566
Rhabdomyosarcoma :@0.554545:0.707021:0.758820:0.707021:0.758820:0.691265:0.554545:0.691265:0.011680:0.011738:0.013143:0.013123:0.013181:0.012604:0.018049:0.010314:0.012604:0.007466:0.013143:0.005655:0.012450:0.012604:0.018049:0.013143:0.005330
Melphalan :@0.524242:0.733812:0.641407:0.733812:0.641407:0.715996:0.524242:0.715996:0.019242:0.013683:0.005131:0.014111:0.012828:0.014111:0.005131:0.014111:0.012828:0.005987
n :@0.524242:0.747865:0.537570:0.747865:0.537570:0.739425:0.524242:0.739425:0.009762:0.003566
 :@0.554542:0.747865:0.558108:0.747865:0.558108:0.739425:0.554542:0.739425:0.003566
Multiple myeloma :@0.554545:0.750984:0.726803:0.750984:0.726803:0.735228:0.554545:0.735228:0.017684:0.011699:0.003848:0.006523:0.003848:0.013123:0.003848:0.012508:0.005330:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.005330
n :@0.524242:0.763891:0.537570:0.763891:0.537570:0.755451:0.524242:0.755451:0.009762:0.003566
 :@0.554542:0.763891:0.558108:0.763891:0.558108:0.755451:0.554542:0.755451:0.003566
Ovarian cancer:@0.554545:0.767011:0.703000:0.767011:0.703000:0.751255:0.554545:0.751255:0.016722:0.010660:0.013143:0.005792:0.003848:0.013143:0.011738:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
n :@0.524242:0.779918:0.537570:0.779918:0.537570:0.771477:0.524242:0.771477:0.009762:0.003566
 :@0.554542:0.779918:0.558108:0.779918:0.558108:0.771477:0.554542:0.771477:0.003566
Neuroblastoma in childhood :@0.554545:0.783037:0.825965:0.783037:0.825965:0.767281:0.554545:0.767281:0.014239:0.012508:0.011699:0.005711:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.018049:0.013143:0.005330:0.003848:0.011738:0.005330:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012594:0.013181:0.005330
n :@0.524242:0.795944:0.537570:0.795944:0.537570:0.787504:0.524242:0.787504:0.009762:0.003566
 :@0.554542:0.795944:0.558108:0.795944:0.558108:0.787504:0.554542:0.787504:0.003566
Adjunctive in breast cancer:@0.554545:0.799063:0.813430:0.799063:0.813430:0.783307:0.554545:0.783307:0.014239:0.013181:0.003906:0.011699:0.011738:0.012450:0.006523:0.003848:0.010660:0.012508:0.005330:0.003848:0.011738:0.005330:0.013123:0.005713:0.012508:0.013143:0.007466:0.006523:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792
Bendamustine:@0.524242:0.825853:0.671767:0.825853:0.671767:0.808038:0.524242:0.808038:0.012401:0.013683:0.012828:0.014111:0.014111:0.020098:0.012828:0.009407:0.006414:0.005131:0.012828:0.013683
n :@0.524242:0.839907:0.537570:0.839907:0.537570:0.831467:0.524242:0.831467:0.009762:0.003566
  First-line CLL treatment (Binet stage B :@0.554545:0.843026:0.900862:0.843026:0.900862:0.827270:0.554545:0.827270:0.005330:-0.005330:0.009333:0.003848:0.005792:0.007466:0.006523:0.006388:0.003848:0.003848:0.011738:0.012508:0.005330:0.015644:0.008890:0.008890:0.005330:0.006523:0.005707:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.007100:0.011045:0.003848:0.011738:0.012508:0.006523:0.005330:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330:0.011045:0.005330
or C) in patients for whom fludarabine :@0.554545:0.858465:0.913781:0.858465:0.913781:0.842709:0.554545:0.842709:0.012604:0.005792:0.005330:0.015644:0.007100:0.005330:0.003848:0.011738:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.006042:0.012604:0.005792:0.005330:0.015990:0.011738:0.012604:0.018049:0.005330:0.004666:0.004666:0.011699:0.013181:0.013143:0.005792:0.013143:0.013123:0.003848:0.011738:0.012508:0.005330
combination chemotherapy is not :@0.554545:0.873903:0.878202:0.873903:0.878202:0.858147:0.554545:0.858147:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.003848:0.007466:0.005330:0.011738:0.012604:0.006523:0.005330
appropriate:@0.554545:0.889341:0.667194:0.889341:0.667194:0.873585:0.554545:0.873585:0.013143:0.013123:0.013123:0.005719:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508
n :@0.524242:0.902248:0.537570:0.902248:0.537570:0.893808:0.524242:0.893808:0.009762:0.003566
 :@0.554542:0.902248:0.558108:0.902248:0.558108:0.893808:0.554542:0.893808:0.003566
Indolent CD20-positive non-Hodgkin’s :@0.554545:0.905367:0.909086:0.905367:0.909086:0.889611:0.554545:0.889611:0.004349:0.011738:0.013181:0.012604:0.003848:0.012508:0.011738:0.006523:0.005330:0.015644:0.014316:0.010660:0.010660:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330:0.011738:0.012604:0.011738:0.006388:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330
lymphoma in combination with :@0.554545:0.920806:0.850089:0.920806:0.850089:0.905050:0.554545:0.905050:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330:0.003848:0.011738:0.005330:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330
rituximab:@0.554545:0.936244:0.639808:0.936244:0.639808:0.920488:0.554545:0.920488:0.005792:0.003848:0.006523:0.011699:0.009236:0.003848:0.018049:0.013143:0.013123
DRUG-CLASS OVERVIEW:@0.084848:0.038601:0.357590:0.038601:0.357590:0.019343:0.084848:0.019343:0.017498:0.014276:0.015405:0.020508:0.007808:0.019121:0.010866:0.017404:0.011712:0.011712:0.006515:0.020438:0.016510:0.012606:0.013356:0.016510:0.005315:0.012606:0.022578